Search Details

Word: reviewers (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

...death system, in fact, needed reform; the typical capital appeal costs the state more than imprisoning someone for life. Congress responded with the impressively titled Antiterrorism and Effective Death Penalty Act of 1996, which makes it increasingly difficult for defendants to secure federal review of their cases. Thanks to such laws, the appeals process won't be taking nine years anymore--and those falsely convicted will have less chance of leaving death row alive...

Author: /time Magazine | Title: CRIME AND PUNISHMENT: DEATH OR LIFE? | 6/16/1997 | See Source »

TIME checked out America's secret government agencies last week on the Web. Our unclandestine review...

Author: /time Magazine | Title: Notebook: Jun. 9, 1997 | 6/9/1997 | See Source »

Essentially, the new FDA-process fast track offers conditional approval for appropriate drugs based on clinical trials that are smaller and faster than normal. The agency also allows "rolling submissions," meaning it will accept and release initial reviews of drug components that are prepared earlier than the rest. For Agouron the difference was startling: the FDA's review of the Viracept application took a total of only 83 days; in 1992 the average length of time for FDA drug approval was 19 months...

Author: /time Magazine | Title: PHARMACEUTICALS: BALANCING ACT | 6/9/1997 | See Source »

...patients but also the firm's bottom line. Agouron spent the past 12 years pumping all its income--$56 million last year--into research on the technology and procedures later used to bring Viracept to market. Agouron's net loss last year was $19.5 million, and under normal FDA review, Viracept would still not have been able to earn money for several more years. Under the new rules, however, Agouron can profit immediately from sales of Viracept, which, as one of only four protease inhibitors currently revolutionizing AIDS treatments, is sure to sell well. Viracept could earn $500 million...

Author: /time Magazine | Title: PHARMACEUTICALS: BALANCING ACT | 6/9/1997 | See Source »

...sorry that your review of new animation and cartoon books [SHOW BUSINESS, May 19] failed to mention my father Robert McKimson, who was with Warner Bros. Cartoons studio as an animator and director from 1931 until it closed in 1963. He directed 175 cartoons and created the Tasmanian Devil, Foghorn Leghorn, Sylvester Jr. and the original Speedy Gonzales. He was nominated for two Academy Awards and was credited in 1944 by the Library of Congress as the author-artist of Bugs Bunny. The books you covered in this article did little to expose the artistic talent that was part...

Author: /time Magazine | Title: Letters: Jun. 9, 1997 | 6/9/1997 | See Source »

Previous | 175 | 176 | 177 | 178 | 179 | 180 | 181 | 182 | 183 | 184 | 185 | 186 | 187 | 188 | 189 | 190 | 191 | 192 | 193 | 194 | 195 | Next